An Adaptive Study of the Pharmacokinetics of Favipiravir in Patients With Severe Influenza.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 07 Jan 2019
At a glance
- Drugs Favipiravir (Primary) ; Oseltamivir
- Indications Influenza virus infections
- Focus Pharmacokinetics
- 31 Dec 2018 Planned End Date changed from 10 Dec 2018 to 10 Feb 2019.
- 31 Dec 2018 Status changed from recruiting to active, no longer recruiting.
- 20 Sep 2018 Planned End Date changed from 10 Aug 2018 to 10 Dec 2018.